<DOC>
	<DOCNO>NCT02049307</DOCNO>
	<brief_summary>The purpose study evaluate potential effectiveness losartan ( 100mg daily ) reduce inflammation improve immune recovery .</brief_summary>
	<brief_title>Losartan Reduce Inflammation Fibrosis Endpoints HIV Trial</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>HIV infection ( verified previous positive antibody detectable HIV RNA level ) Age &gt; 50 year Receiving continuous ART &gt; = 2 year ( regimen change &gt; 6 month prior enrollment allow ) HIV RNA level &lt; 200 copies/mL &gt; = 1 year ( 1 measure &gt; = 200 allow also &lt; 1000 precede follow value &lt; 200 copies/mL ) Blood CD4+ Tcell count &lt; 600 cells/mm cub Systolic blood pressure &gt; 120 mmHg ( mean value &gt; = 2 measure obtain ) Estimated glomerular filtration rate ( GFR ) &gt; 30 mL/min/1.73 square Do anticipate start stop statin aspirin therapy study Pregnancy breastfeed A contraindication take angiotensin receptor blocker ( ARB ) ( e.g. , cirrhosis , prior angioedema angiotensinconverting enzyme inhibitor ( ACEI ) , use drug potential druginteraction [ e.g. , rifaximin ] ) A clinical indication ARB ACEI therapy ( e.g. , cardiovascular disease ( CVD ) , stroke , diabetes mellitus ( DM ) ) Current treatment ARB medication overlap mechanism ( e.g. , ACEI aldosterone antagonist ) Current treatment immunomodulatory drug within past 6 month Current hepatitis treatment ( e.g. , interferon , ribavirin ) within past 6 month Serum potassium &gt; 5.0 millimoles per liter ( mmol/L ) within 3 month entry Invasive cancer prior year receive cancer treatment ( include carcinomainsitu basal cell cancer skin ) Cirrhosis endstage liver disease Rheumatologic chronic inflammatory disease ( e.g. , systematic lupus erythematous , psoriasis , rheumatoid arthritis , vasculitis , sarcoidosis , Crohn 's disease )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>